Top Tech Companies (44)
Don't see your company?
Create a company profile
We believe that AI has the potential to revolutionize how cancer and other complex diseases are diagnosed and treated. We also believe that AI is a tool, not an identity – without access to high quality data and a scientifically rigorous, transparent approach to model development, AI is just a buzzword. That’s where we come in. Aignostics is a spin-off from one of Europe's largest and most prestigious university hospitals (Charité), with employees in Berlin and New York. We're a growing team of over 100 interdisciplinary professionals who work with academic and leading life sciences partners to catalyze the next generation in precision medicine for cancer.
Metsera is a clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and metabolic diseases. Metsera is advancing a broad portfolio of oral and injectable incretin, non-incretin and combination therapies with potential best-in-class profiles to address multiple therapeutic targets and meet the future needs of a rapidly evolving weight loss treatment landscape. Founded in 2022 by Population Health Partners and ARCH Venture Partners, Metsera has raised $290 million in financing from leading healthcare investors and is based in New York City.
With a potential 60 percent increase in the number of cancer cases globally in the next two decades and a decrease in the number of pathologists relative to this diagnostic demand, the need to expedite advancements in pathology is pressing. This issue is further exacerbated by the fact that pathology — despite being the foundation of diagnosis — has yet to become digital. Led by a team of experts in pathology, machine learning, healthcare, and business, Paige strives to make it possible to not only provide additional information from digital slides to help pathologists perform their diagnostic work efficiently and accurately, but also to go beyond this traditional work to extract new diagnostic information from pathology slides and patient samples that have the potential to support informed treatment pathways for patients. Paige technology is also helping life sciences companies evaluate and design personalized treatments for patients.
Our mission is to fight cancer cooperatively instead of individually by connecting scientists and pathologists for online collaboration. HistoWiz provides fast, global access to digital whole-slide images, online collaboration tools, low-cost data management, and experimental pathology expertise. The web-based platform accelerates information exchange among scientists, pathologists, and everyday people who are interested in learning more about a certain type of cancer.
Flywheel is a creative agency that supports top healthcare companies with strategic consulting and innovative marketing and training services. Our clients are pharmaceutical, medical device, and biotech ventures that seek more effective engagement with their customers - and we help them make that happen.
.png)
Valo is a technology company built to transform the drug discovery and development process using human-centric data and AI-powered computation. Valo is fully integrating human-centric data across the entire drug development lifecycle into a single unified architecture, thereby accelerating the discovery and development of life-changing drugs while simultaneously reducing the cost, time, and failure rate. The company’s Opal Computational Platform™ consists of an integrated set of capabilities designed to transform data into valuable insights that may accelerate discoveries and enable Valo to advance a robust pipeline of programs across cardiovascular metabolic renal, oncology, and neurodegenerative disease.
RegFront is building technology to improve the speed, quality, and consistency of drug development to help bring life-changing treatments to market more effectively. The global drug R&D market spends tens of billions of dollars annually with consistently decreasing returns on investment. There are countless factors, but the one we’re addressing first is the inefficiencies in managing the regulatory process - communication with regulatory agencies like the FDA and developing strategies based on regulatory requirements.
Since 2013, Lightmatter has built digital products for all kinds of founders, teams, and industries. Building is intoxicating. It's core to our DNA. As we've grown, we noticed that the work we were most proud of, the work that had the greatest impact on others, was in health. Our clients were building products to solve problems we've all experienced as patients: broken telehealth portals, apps that neglected usability, and software that compromised PHI. Covid heightened just how inadequate these digital health experiences are when we’ve needed them most. We've narrowed our focus to health because the digital products we build can have an immediate impact on the health, wellness, and HCIT companies we serve...and the patients that they serve. To make any meaningful change in the world, we have to take care of the humans in it.
_0.png)
We lead the global clinical trial performance improvement market by efficiently managing the patient experience through highly-personalized patient-centric services, unrivaled processes, and our team of professional experts. We streamline communication and coordination among clinical trial patients, sites, and stakeholders. We develop mutually beneficial, long-term relationships with clients and vendors who share our dedication and vision to humanize the patient experience.
Kingdom designs and supplies Superculture™ ingredients that make it easy for food and beverage manufacturers to create products that are healthier, more natural, and more sustainable. Our vision is to replace artificial chemicals and genetically-modified organisms with natural Superculture™ ingredients as the backbone of the modern CPG industry.
Celmatix is a next-generation women’s health company transforming the way women and their physicians leverage genomics and data to make more informed, proactive reproductive health decisions. Since its foundation in 2009, Celmatix has been committed to empowering women with genetic insights about their fertility and reproductive health.
Evvy is a female-founded startup building a new understanding of the female body. Our at-home vaginal microbiome test is the first to leverage metagenomic sequencing to help anyone with a vagina understand what’s up down there, why it matters, and what they can do about it. Why the vaginal microbiome? Turns out, at least 30% of people with vaginas suffer from imbalances in the vaginal microbiome every year (read: bacterial vaginosis, yeast infections, and UTIs). What’s more — the latest research has uncovered groundbreaking links between the vaginal microbiome and infertility, STIs, preterm birth, gynecologic cancers, and more. But even though the vaginal microbiome is an important biomarker, women and people with vaginas have never had access to that information about their own bodies — until now.
Helaina is a VC-backed biotech startup creating a new category of functional food products. We're the first company to put human proteins into food, starting with making the most human-like infant formula in order to empower and equip parents with more choice in their infant’s nutrition. Helaina’s R&D harnesses the power of naturally occurring biological processes in tandem with modern advances in the space of synthetic biology, fermentation, and improved industrial processing. We developed a novel precision fermentation platform to unlock a suite of functional proteins, which allows us to create infant formula with health benefits previously only available through breast milk.
Scismic is a tech platform built by scientists to help biotechs grow qualified and diverse scientific teams. Our specialized algorithm accurately targets relevant candidates for faster hiring. We are funded by the NIH to reduce bias in candidate evaluation through our gender- and race-blind skills matching technology, so you can hire scientists from all walks of life with the skills you need.
PWNHealth is a national clinician network serving all 50 states and Puerto Rico with telehealth and telegenetic services. Our model enables safe and easy access to diagnostic testing. Our solutions provide the clinical, legal, and technological framework to facilitate large-scale consumer testing across key healthcare markets.
Kallyope is a platform biotechnology company dedicated to unlocking the therapeutic potential of the gut-brain axis. The company integrates cutting-edge technologies in sequencing, computational biology, neural imaging, cellular and molecular biology, and human genetics to provide an understanding of gut-brain biology .
BenevolentAI is the global leader in the development and application of artificial intelligence (“AI”) for scientific innovation. We aim to accelerate the journey from inventive ideas to medicines for patients by developing AI to generate new treatments for some of the world’s 8,000 untreated diseases.
EyeBio is a privately held ophthalmology biotechnology company dedicated to developing and delivering a new generation of therapies to protect, restore, and improve vision in patients with sight-threatening eye diseases.
OnCusp Therapeutics, Inc., headquartered in New York City, is a biopharmaceutical company dedicated to transforming cutting-edge preclinical innovation into clinically validated treatments for cancer patients worldwide. OnCusp was co-founded by Dr. Bing Yuan, Dr. Eric Slosberg, and Dr. Andy Fu, and has built a strong team of accomplished veterans with proven track records in building startup biotechs, leading successful preclinical and clinical programs, and creating value through global partnerships. The company is committed to accelerating the advancement of globally competitive oncology assets for patients.
The OpenTrons One is a personal liquid handling robot geared towards biotech innovation.
